We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Market for Proteomics Research Tools Facing Sharp Growth Trend

By LabMedica International staff writers
Posted on 05 Oct 2014
Print article
A report recently released to the biotech industry predicts sharp growth in research efforts in the field of proteomics with concurrent growth in sales of research supplies and equipment.

The report, “Proteomics Markets for Research and IVD Applications,” which was prepared by Kalorama Information (New York, NY, USA), indicated that the USD 5 billion market for proteomics instruments, reagents, and testing for research and diagnostic applications was likely to grow rapidly over the next several years, despite cost pressures generally in research.

Proteomics is the study of protein structure and function. At the cellular level, investigators attempt to determine which proteins are expressed, when and where they are expressed, what is their structure in both active and inactive states, what roles they play in the life of the cell, and how they interact with other proteins and molecules.

While many different types of technologies are used to study proteins, demands for the three main technologies: mass spectrometry, antibodies (or antibody capture), and knowledge bases are expected to grow significantly.

“It is enormously difficult to study proteins, but hard-fought discoveries made in the research enable biomarker discovery, drug discovery, new IVDs, and personalized solutions,” said Bruce Carlson, publisher of Kalorama Information. “There are many manufacturers willing to assist customers with technologies, creating a vibrant market. New platforms based on a wide range of proteomics technologies have already started to reach the in vitro diagnostics market. The major question today is not whether or not these novel platforms and biomarkers will emerge as a significant market opportunity in the IVD market, but when. How long will it take for companies to obtain the required regulatory approvals? How long will it take for the tests to penetrate these markets? The answers to this question will vary with individual platforms and assays, and will depend on factors such as the unmet need, how well the new platform and assays meet that need, costs, etc.”

Related Links:

Kalorama Information


Gold Member
Turnkey Packaging Solution
HLX
Automated Blood Typing System
IH-500 NEXT
New
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Tabletop Centrifuge
Mikro 185

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.